H.R. 6083 (111th): Stem Cell Therapeutic and Research Reauthorization Act of 2010

The federal budget process occurs in two stages: appropriations, which set overall spending limits by agency or program, and authorizations, which direct how federal funds should (or should not) be used. Appropriation and authorization provisions are typically made for single fiscal years. A reauthorization bill like this one renews the authorizations of an expiring law.
Introduced:

Aug 10, 2010
111th Congress, 2009–2010

Status:
Enacted as S. 3751 (companion bill)
Sponsor:

Christopher “Chris” Smith

Representative for New Jersey's 4th congressional district

Republican

Text:

Read Text »
Last Updated: Aug 10, 2010
Length: 10 pages

See Instead:

S. 3751 (same title)
Enacted — Signed by the President — Oct 8, 2010

H.R. 6081 (same title)
Reported by Committee — Sep 23, 2010

About the bill

Full Title

To amend the Stem Cell Therapeutic and Research Act of 2005.

The bill’s titles are written by its sponsor.

Read CRS Summary >

History

Aug 10, 2010
 
Introduced

This is the first step in the legislative process.

This page is about a bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

Links & tools

Primary Source

Congress.gov

Congress.gov is updated generally one day after events occur. Legislative activity since the last update may not be reflected on GovTrack. Data via congress project.

Citation

Click a format for a citation suggestion: